EXPRESSION OF BETA-DEFENSIN-2 IN HUMAN GASTRIC TUMORS: A PILOT STUDY

Markeeva N.V.1, Igor Lisovskiy2, Valeriy Lyzogubov3, Vasilij Usenko4, Maria Soldatkina5, Serhey Merentsev6, Serhey Zaitsev7, Yuriy Kondratskii8, Anatoliy Tofan9, Serhey Osinskiy10, Petro Pogrebnoy11

Summary. The present work was aimed on the study of patterns of human beta-defensin-2 (hBD-2) expression in human gastric tumors. Materials and methods: 17 samples of surgically resected human gastric adenocarcinoma paired with respective normal tissue controls have been analyzed for the expression of hBD-2 by semi-quantitative RT-PCR and by immunohistochemical analysis using anti-hBD-2 monoclonal antibodies (mAbs) generated against recombinant hBD-2 by standard hybridoma technology. Results: The hyperexpression of hBD-2 on mRNA and protein levels was registered in 6 from 17 gastric tumor samples compared to respective controls; however, hBD-2 expression patterns seems not be related to the differentiation grade and stage of tumors and the presence of anti-Helicobacter pylori-antibodies in the blood serum of the patients. Conclusion: In human gastric adenocarcinomas expression of hBDs possesses heterogeneic character; the research on larger cohort of the patients with gastric cancer should be further performed.

No Comments » Add comments
Leave a comment